Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 242.71 USD -0.37%
Market Cap: 35.6B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Research & Development Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Research & Development
-$311.3m
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-8%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.5B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Stryker Corp
NYSE:SYK
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.7B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.1B
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-20%

See Also

What is Resmed Inc's Research & Development?
Research & Development
-311.3m USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Research & Development amounts to -311.3m USD.

What is Resmed Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-10%

Over the last year, the Research & Development growth was -4%. The average annual Research & Development growth rates for Resmed Inc have been -11% over the past three years , -10% over the past five years , and -10% over the past ten years .

Back to Top